Olivia Vizier

Getting to the Root of the Disease: Developing Drugs Against the Hard-to-Target Wnt Pathway

“Successful drugs targeting the Wnt pathway haven’t been developed yet because the Wnt pathway is so essential to all cells,” commented Yusuf Yazici, MD, Chief Medical Officer of Samumed. “Previous drugs in development have shown many off-target effects at effective doses, rendering them unsafe for use.”

Getting to the Root of the Disease: Developing Drugs Against the Hard-to-Target Wnt Pathway Read More »

RNA Therapies Emerge for Genetic Diseases

Some biopharmaceutical enterprises are even specializing in specific mechanisms of action by targeting and modifying RNA through temporary and ongoing treatment to avoid safety concerns that may arise from permanent gene therapy alterations. In this article, Daniel de Boer, CEO at ProQR Therapeutics, will discuss how they are advancing RNA therapies in retinal disorders.

RNA Therapies Emerge for Genetic Diseases Read More »